Daan Gene Balance Sheet Health
Financial Health criteria checks 5/6
Daan Gene has a total shareholder equity of CN¥8.6B and total debt of CN¥146.3M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are CN¥10.0B and CN¥1.4B respectively.
Key information
1.7%
Debt to equity ratio
CN¥146.26m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥934.51m |
| Equity | CN¥8.60b |
| Total liabilities | CN¥1.38b |
| Total assets | CN¥9.98b |
Recent financial health updates
Health Check: How Prudently Does Daan Gene (SZSE:002030) Use Debt?
Oct 24
Is Daan Gene (SZSE:002030) Weighed On By Its Debt Load?
May 02Recent updates
Health Check: How Prudently Does Daan Gene (SZSE:002030) Use Debt?
Oct 24Daan Gene Co., Ltd. (SZSE:002030) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Aug 20Is Daan Gene (SZSE:002030) Weighed On By Its Debt Load?
May 02Daan Gene's (SZSE:002030) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 05Calculating The Fair Value Of Daan Gene Co., Ltd. (SZSE:002030)
Mar 25Daan Gene Co., Ltd. (SZSE:002030) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Mar 06Financial Position Analysis
Short Term Liabilities: 002030's short term assets (CN¥5.0B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 002030's short term assets (CN¥5.0B) exceed its long term liabilities (CN¥152.1M).
Debt to Equity History and Analysis
Debt Level: 002030 has more cash than its total debt.
Reducing Debt: 002030's debt to equity ratio has reduced from 35.3% to 1.7% over the past 5 years.
Debt Coverage: 002030's debt is well covered by operating cash flow (429.6%).
Interest Coverage: Insufficient data to determine if 002030's interest payments on its debt are well covered by EBIT.